Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-135144
Filing Date
2024-12-11
Accepted
2024-12-11 06:15:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 crdf_12.10.24_-_424b5.htm 424B5 768469
2 GRAPHIC img140725226_0.jpg GRAPHIC 117905
3 GRAPHIC img140725226_1.jpg GRAPHIC 176318
4 GRAPHIC img140725226_2.jpg GRAPHIC 117905
  Complete submission text file 0000950170-24-135144.txt   1322939
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264148 | Film No.: 241540066
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)